Tag Archive for: takeda

Covid-19: The Industry Response – How Are we Doing?

Chair: Clive Cookson, Science Editor, Financial Times Sean Marett, Chief Business and Chief Commercial Officer, BioNTech Professor James Logan, Head of Department of Disease Control, London School of Hygiene and Tropical Medicine Kate Bingham, Chair of UK Vaccine Taskforce & Managing Partner of SV Health Investors Rajeev Venkayya, MD, President Global Vaccine Business Unit, Takeda […]

Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home

Enzyre, which is developing breakthrough ambulant diagnostic technology for coagulation testing, today announced that it has entered into a research collaboration agreement with Takeda Pharmaceutical Company Limited (Takeda) to develop a diagnostic device that will enable hemophilia patients to determine their coagulation status at home. Hemophilia is a rare genetic disorder that affects approximately 400,000 […]